Publication | Closed Access

In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection

Aspergillus Fumigatus InfectionAntifungal AgentPosaconazole TherapyAntifungal AgentsMedicineNovel Invertebrate ModelMicrobiologyPharmacologyAntimicrobial ResistanceFungal PathogenDrug Resistance